1 – 10 of 237
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition
- Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
- Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancer
- Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
- Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category
- Cytokines and Janus kinase/signal transducer and activator of transcription signaling in prostate cancer : overview and therapeutic opportunities
-
Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study
Stuparu, Andreea D. ; Meyer, Catherine A.L. ; Evans-Axelsson, Susan L. LU
;
Lückerath, Katharina
;
Wei, Liu H.
;
Kim, Woosuk
;
Poddar, Soumya
;
Mona, Christine E.
;
Dahlbom, Magnus
and
Girgis, Mark D.
, et al.
(2020)
In Theranostics
10(6).
p.2612-2620
Mark
- Recent advances of PET imaging in clinical radiation oncology
- Do negative intrusive thoughts at diagnosis predict impaired quality of life, depressed mood and waking up with anxiety 3, 12 and 24 months after radical prostatectomy?–a longitudinal study
- 2019
- Quality of Life After Open Radical Prostatectomy Compared with Robot-assisted Radical Prostatectomy